FindTrial
Sign In

To Study the Effect of Gagana Parpati

Screening of Free Radical Scavening Activity And Immunomodulatory Effect of Gagan Parpati An experimental study - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/084948
Enrollment
5
Registered
2025-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Saurabh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: healthy adult humans

Exclusion criteria

Exclusion criteria: Metabolic disorders like Diabetes mellitus, hypertension, immune disorders, etc Subjects in the convalescent phase of any infection. Subjects who are on any medications within the duration of 2 to 3 months.

Design outcomes

Primary

MeasureTime frame
1. Nitroblue tetrazolim assay for respiratory burst. 2. Phagocytosis for phagocytic function. 3. Candidal assay for phagocytic function. 4. Chemotaxis to assess the motility of phagocytic cells.Timepoint: 1st day—

Secondary

MeasureTime frame
imuunne responsesTimepoint: within 15 days—

Countries

India

Contacts

Public ContactSaurabh

KLE university

drjadar@yahoo.co.in9448301308

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026